60 related articles for article (PubMed ID: 11249710)
1. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase.
Lesburg CA; Radfar R; Weber PC
Curr Opin Investig Drugs; 2000 Nov; 1(3):289-96. PubMed ID: 11249710
[TBL] [Abstract][Full Text] [Related]
2. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
Wang YK; Rigat KL; Roberts SB; Gao M
Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
[TBL] [Abstract][Full Text] [Related]
3. Specificity and mechanism analysis of hepatitis C virus RNA-dependent RNA polymerase.
Johnson RB; Sun XL; Hockman MA; Villarreal EC; Wakulchik M; Wang QM
Arch Biochem Biophys; 2000 May; 377(1):129-34. PubMed ID: 10775451
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of active hepatitis C virus RNA-dependent RNA polymerase.
Ryu K; Kim KH; Yoo SY; Lee EY; Lim KH; Min MK; Kim H; Choi SI; Seong BL
Protein Expr Purif; 2010 Jun; 71(2):147-52. PubMed ID: 20060472
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
[TBL] [Abstract][Full Text] [Related]
6. The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase.
Adachi T; Ago H; Habuka N; Okuda K; Komatsu M; Ikeda S; Yatsunami K
Biochim Biophys Acta; 2002 Nov; 1601(1):38-48. PubMed ID: 12429501
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence.
Tomei L; Vitale RL; Incitti I; Serafini S; Altamura S; Vitelli A; De Francesco R
J Gen Virol; 2000 Mar; 81(Pt 3):759-67. PubMed ID: 10675414
[TBL] [Abstract][Full Text] [Related]
8. A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase.
Lee JC; Tseng CK; Chen KJ; Huang KJ; Lin CK; Lin YT
Anal Biochem; 2010 Aug; 403(1-2):52-62. PubMed ID: 20382106
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A
Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620
[TBL] [Abstract][Full Text] [Related]
10. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure.
O'Reilly EK; Kao CC
Virology; 1998 Dec; 252(2):287-303. PubMed ID: 9878607
[TBL] [Abstract][Full Text] [Related]
11. Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays.
Carroll SS; Sardana V; Yang Z; Jacobs AR; Mizenko C; Hall D; Hill L; Zugay-Murphy J; Kuo LC
Biochemistry; 2000 Jul; 39(28):8243-9. PubMed ID: 10889032
[TBL] [Abstract][Full Text] [Related]
12. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
[TBL] [Abstract][Full Text] [Related]
13. Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.
Zhong W; Ferrari E; Lesburg CA; Maag D; Ghosh SK; Cameron CE; Lau JY; Hong Z
J Virol; 2000 Oct; 74(19):9134-43. PubMed ID: 10982360
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site.
Lesburg CA; Cable MB; Ferrari E; Hong Z; Mannarino AF; Weber PC
Nat Struct Biol; 1999 Oct; 6(10):937-43. PubMed ID: 10504728
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
Popovici-Muller J; Shipps GW; Rosner KE; Deng Y; Wang T; Curran PJ; Brown MA; Siddiqui MA; Cooper AB; Duca J; Cable M; Girijavallabhan V
Bioorg Med Chem Lett; 2009 Nov; 19(22):6331-6. PubMed ID: 19819138
[TBL] [Abstract][Full Text] [Related]
16. RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities.
May MM; Lorengel H; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
Biochim Biophys Acta; 2011 Oct; 1814(10):1325-32. PubMed ID: 21621653
[TBL] [Abstract][Full Text] [Related]
17. Polymerases of hepatitis C viruses and flaviviruses: structural and mechanistic insights and drug development.
Caillet-Saguy C; Lim SP; Shi PY; Lescar J; Bressanelli S
Antiviral Res; 2014 May; 105():8-16. PubMed ID: 24561230
[TBL] [Abstract][Full Text] [Related]
18. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Ivanov AV; Kozlov MV; Kuzyakin AO; Kostyuk DA; Tunitskaya VL; Kochetkov SN
Biochemistry (Mosc); 2004 Jul; 69(7):782-8. PubMed ID: 15310279
[TBL] [Abstract][Full Text] [Related]
19. Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole.
Asthana S; Shukla S; Vargiu AV; Ceccarelli M; Ruggerone P; Paglietti G; Marongiu ME; Blois S; Giliberti G; La Colla P
Biochemistry; 2013 May; 52(21):3752-64. PubMed ID: 23627712
[TBL] [Abstract][Full Text] [Related]
20. Structure of hepatitis C virus polymerase in complex with primer-template RNA.
Mosley RT; Edwards TE; Murakami E; Lam AM; Grice RL; Du J; Sofia MJ; Furman PA; Otto MJ
J Virol; 2012 Jun; 86(12):6503-11. PubMed ID: 22496223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
